Rare diseases
Investigational molecules
Locations
Back to Portugal489 clinical trials in Porto, Portugal across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
PortugalStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
PortugalStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
PortugalStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
PortugalStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
PortugalStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
PortugalSafety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study
PortugalStudy of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer
PortugalPortugalPortugalPortugalSingle‑dose Bioavailability of Gliclazide Modified‑Release Tablets in Healthy Volunteers (Type 2 Diabetes)
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on polypoidal choroidal vasculopathy and rare genetic conditions like PMM2-CDG, exploring new treatment approaches to improve patient outcomes.
Groundbreaking studies in chronic myelogenous leukemia, multiple myeloma, and advanced malignancies, including research on novel therapies for non-small cell lung cancer.
Comprehensive research into conditions like hidradenitis suppurativa, plaque psoriasis, and pyoderma gangrenosum, evaluating new therapeutic approaches.
Studies examining hypertrophic cardiomyopathy, familial hypercholesterolemia, and innovative treatments for obesity.
Investigating treatments for Dravet Syndrome, menstrual migraine, and rare conditions like Niemann-Pick disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
